Dr. Hossein Alimadadian, MD

Dr. Alimadadian practices at Pavilion Surgery Center in Orange, California.

Dr. Alimadadian's NPI, 1285664029, was assigned on July 4, 2006. Dr. Alimadadian graduated from Ahvaz Jundishapur University of Medical Sciences in 1970. Dr. Alimadadian holds California license A25808.

Dr. Alimadadian's primary practice is Pavilion Surgery Center, at 1140 W La Veta Ave, Orange, CA 92868 in Orange County. The practice phone is (714) 744-8711.

Dr. Alimadadian's primary practice is Pavilion Surgery Center in Orange, California. The medical group on file is Orange County Heart Institute. Dmand AI also links Dr. Alimadadian to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alimadadian practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Alimadadian's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Alimadadian is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Alimadadian's licenses on file in 2 states: California and Illinois.

Dmand AI lists cardiac catheterization among the conditions Dr. Alimadadian treats.

CMS data shows 1,666 Medicare services from Dr. Alimadadian across 14 procedure codes in 2024, for 367 Medicare patients. Medicare paid $158,824 for them. Every service was in an office.

CMS counts 367 Medicare patients who saw Dr. Alimadadian in 2024. The largest group is 75 to 84, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alimadadian's median patient age at 76, with 39% women.

In 2024, Dr. Alimadadian wrote 2,586 Medicare Part D claims for 362 patients. 77% of them were for generic drugs. CMS names the drug for 2,233 of them, across 40 drugs with 11 or more claims each, at $541,503 in total drug cost. In 2023, CMS named 2,391 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Alimadadian for performance year 2024, reported individually.

Dmand AI links 8 papers to Dr. Alimadadian. The most frequent topics are Coronary Artery Bypass, Length of Stay and Postoperative Complications. Dr. Alimadadian has published most often in J Card Surg. Dr. Alimadadian's most frequent co-authors are Dan E. Gutfinger, MD and Arthur Selvan, MD.

CMS Open Payments shows 390 general payments to Dr. Alimadadian from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,078.

Dr. Alimadadian graduated from Ahvaz Jundishapur University of Medical Sciences in 1970.

Dr. Alimadadian is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.